PD-1, a receptor found on the surface of tumour-specific activated T cells, B lymphocytes, and natural killer cells, interacts with its ligand, programmed cell death ligand-1 (PD-L1)—a transmembrane protein expressed by cancer cells. Here, PDCD1 is linked to cancer.